▲ Peaking
Business
Experts urge FDA to set clear safety and access standards for psychedelic drugs
A September 14 FDA hearing pushes psychedelic drug standards to the forefront as veterans and the public demand faster access.
Ptsd
5 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Ptsd
This hub groups 5 separate news trends connected to Ptsd, spanning August 7, 2026 through September 15, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 39 article observations and 39 source signals, led by Entertainment, Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Scientists uncover shared biology behind profound fatigue in five major illnesses
A single cellular blueprint now links five debilitating fatigue disorders, opening doors for unified therapies.
◼ Archived
Entertainment
🔮 holds ✗
‘Onslaught’ Review: Adam Wingard’s Gory Action Throwback Peaks Too Soon
A new action-thriller is sparking debate over its style and substance, as critics weigh in ahead of its release.
◼ Archived
Entertainment
🔮 fades ✓
Paris Jackson opens up about ‘painful’ electroconvulsive therapy. She’s not alone
Paris Jackson is drawing renewed attention to mental health treatment practices following her accounts of electroconvulsive therapy and facility-based care.
◼ Archived
Health
🔮 fades ✓
Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial
A randomized controlled trial published in Nature indicates that the synthetic cannabinoid Dronabinol effectively reduces trauma-related nightmares in PTSD patients.